Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs)

Area of Science:

• Neuroscience
• Stem Cell Biology
• Psychiatry

Background:

• Schizophrenia affects approximately 1% of the global population, necessitating novel therapeutic approaches.
• Current treatments for schizophrenia are limited in efficacy, highlighting the need for better understanding of its pathogenesis.

Purpose of the Study:

• To review recent findings on using induced pluripotent stem cells (iPSCs) to model schizophrenia.
• To discuss insights gained from iPSC-based modeling of schizophrenia's developmental origins.
• To identify critical next steps and challenges in advancing schizophrenia research using iPSCs.

Main Methods:

• Review of recent scientific literature on iPSC applications in schizophrenia research.
• Analysis of studies modeling developmental aspects of schizophrenia pathogenesis using patient-derived iPSCs.

Main Results:

• iPSC models provide valuable insights into the cellular and molecular mechanisms underlying schizophrenia.
• These models facilitate the study of neurodevelopmental trajectories relevant to schizophrenia.

Conclusions:

• Induced pluripotent stem cell technology is a powerful tool for dissecting schizophrenia pathogenesis.
• Further research is needed to translate iPSC findings into effective clinical interventions for schizophrenia.